Viral Pathogenesis and Biosafety Unit, San Raffaele Scientific Institute, Via Olgettina n. 58, 20132 Milano, Italy.
Human Immuno-Virology Unit, San Raffaele Scientific Institute, Via Olgettina n. 58, 20132 Milano, Italy.
Int J Mol Sci. 2022 Mar 11;23(6):3021. doi: 10.3390/ijms23063021.
In addition to CD4 T lymphocytes, myeloid cells and, particularly, differentiated macrophages are targets of human immunodeficiency virus type-1 (HIV-1) infection via the interaction of gp120Env with CD4 and CCR5 or CXCR4. Both T cells and macrophages support virus replication, although with substantial differences. In contrast to activated CD4 T lymphocytes, HIV-1 replication in macrophages occurs in nondividing cells and it is characterized by the virtual absence of cytopathicity both in vitro and in vivo. These general features should be considered in evaluating the role of cell-associated restriction factors aiming at preventing or curtailing virus replication in macrophages and T cells, particularly in the context of designing strategies to tackle the viral reservoir in infected individuals receiving combination antiretroviral therapy. In this regard, we will here also discuss a model of reversible HIV-1 latency in primary human macrophages and the role of host factors determining the restriction or reactivation of virus replication in these cells.
除了 CD4 T 淋巴细胞,髓样细胞,特别是分化的巨噬细胞,也是人类免疫缺陷病毒 1 型(HIV-1)的靶细胞,通过 gp120Env 与 CD4 和 CCR5 或 CXCR4 的相互作用。T 细胞和巨噬细胞都支持病毒复制,尽管存在很大的差异。与活化的 CD4 T 淋巴细胞不同,巨噬细胞中的 HIV-1 复制发生在非分裂细胞中,其特征是体外和体内几乎不存在细胞病变。在评估旨在防止或抑制巨噬细胞和 T 细胞中病毒复制的细胞相关限制因子的作用时,应考虑这些一般特征,特别是在设计针对接受联合抗逆转录病毒疗法的感染个体中病毒储存库的策略时。在这方面,我们还将在这里讨论原发性人巨噬细胞中 HIV-1 潜伏期的可逆模型,以及决定这些细胞中病毒复制限制或重新激活的宿主因素的作用。